Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Net Cash Flow (2023 - 2025)

Camp4 Therapeutics' Net Cash Flow history spans 3 years, with the latest figure at $34.8 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 43.37% year-over-year to $34.8 million; the TTM value through Dec 2025 reached $46.0 million, up 79.46%, while the annual FY2025 figure was $46.0 million, 79.46% up from the prior year.
  • Net Cash Flow for Q4 2025 was $34.8 million at Camp4 Therapeutics, down from $36.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $61.5 million in Q4 2024 and bottomed at -$14.7 million in Q1 2025.
  • The 3-year median for Net Cash Flow is -$10.2 million (2025), against an average of $6.6 million.
  • The largest annual shift saw Net Cash Flow surged 608.82% in 2024 before it plummeted 43.37% in 2025.
  • A 3-year view of Net Cash Flow shows it stood at -$12.1 million in 2023, then soared by 608.82% to $61.5 million in 2024, then tumbled by 43.37% to $34.8 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Net Cash Flow are $34.8 million (Q4 2025), $36.2 million (Q3 2025), and -$10.2 million (Q2 2025).